SO
RARE icon

STRS Ohio’s Ultragenyx Pharmaceutical RARE Stock Holding History

STRS Ohio’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$46.2K Sell
2,205
-3
-0.1% -$68 ﹤0.01% 1951
2025
Q4 		$50.8K Buy
2,208
+60
+3% +$1.97K ﹤0.01% 1976
2025
Q3 		$64.6K Buy
2,148
+1
+0% +$30 ﹤0.01% 1950
2025
Q2 		$78.1K Buy
+2,147
New +$77.4K ﹤0.01% 1936
2021
Q2 		– Sell
-20,700
Closed -$2.36M – 2390
2021
Q1 		$2.36M Buy
20,700
+1,800
+10% +$245K 0.01% 647
2020
Q4 		$2.62M Sell
18,900
-1,400
-7% -$166K 0.01% 617
2020
Q3 		$1.67M Buy
20,300
+11,700
+136% +$970K 0.01% 698
2020
Q2 		$672K Buy
8,600
+4,200
+95% +$278K ﹤0.01% 1100
2020
Q1 		$195K Buy
4,400
+2,700
+159% +$140K ﹤0.01% 1554
2019
Q4 		$72K Sell
1,700
-800
-32% -$33K ﹤0.01% 1836
2019
Q3 		$106K Sell
2,500
-3,200
-56% -$174K ﹤0.01% 1756
2019
Q2 		$361K Hold
5,700
– – ﹤0.01% 1471
2019
Q1 		$395K Buy
5,700
+4,000
+235% +$229K ﹤0.01% 1420
2018
Q4 		$73K Sell
1,700
-3,800
-69% -$208K ﹤0.01% 1818
2018
Q3 		$419K Hold
5,500
– – ﹤0.01% 1459
2018
Q2 		$422K Buy
5,500
+4,300
+358% +$278K ﹤0.01% 1452
2018
Q1 		$61K Buy
+1,200
New +$60.4K ﹤0.01% 1706
2017
Q4 		– Sell
-300
Closed -$15K – 1926
2017
Q3 		$15K Sell
300
-2,800
-90% -$166K ﹤0.01% 1879
2017
Q2 		$192K Hold
3,100
– – ﹤0.01% 1533
2017
Q1 		$210K Buy
3,100
+300
+11% +$22.9K ﹤0.01% 1526
2016
Q4 		$196K Sell
2,800
-1,000
-26% -$70.9K ﹤0.01% 1553
2016
Q3 		$269K Sell
3,800
-2,500
-40% -$160K ﹤0.01% 1483
2016
Q2 		$308K Sell
6,300
-8,300
-57% -$537K ﹤0.01% 1460
2016
Q1 		$924K Sell
14,600
-500
-3% -$32.7K ﹤0.01% 839
2015
Q4 		$1.69M Hold
15,100
– – 0.01% 645
2015
Q3 		$1.45M Buy
15,100
+800
+6% +$91.6K 0.01% 693
2015
Q2 		$1.46M Buy
14,300
+1,000
+8% +$77.6K 0.01% 692
2015
Q1 		$825K Buy
+13,300
New +$739K ﹤0.01% 894

Other funds holding RARE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

STRS Ohio's RARE Position: Q1 2026 in Review

STRS Ohio reduced its Ultragenyx Pharmaceutical (RARE) stake by 0.14% in Q1 2026, selling an estimated $68 and leaving 2,205 shares worth $46.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1951.

STRS Ohio first reported a position in RARE in Q1 2015 and has held it in 28 quarters since. The position peaked at $2.62M in Q4 2020. 295 funds tracked by Wall St. Rank hold RARE as of Q1 2026.

  • STRS Ohio held 2,205 shares of Ultragenyx Pharmaceutical worth $46.2K as of Q1 2026.
  • STRS Ohio sold 3 Ultragenyx Pharmaceutical shares in Q1 2026, an estimated $68.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #1951 holding.
  • STRS Ohio first reported a position in Ultragenyx Pharmaceutical in Q1 2015 and has held it in 28 quarters since.
  • STRS Ohio's Ultragenyx Pharmaceutical position peaked at $2.62M in Q4 2020.
  • 295 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.